In the past 20 years, few diseases have seen as great progress in their treatment as multiple myeloma. With the approval of many new drugs and the limited availability of clinical trials comparing head-to-head the different possible combinations, the choice of the best treatments at each stage of the disease becomes complex as well as crucial since multiple myeloma remains incurable. This article presents a general description of the novelties of the whole treatment of multiple myeloma, from induction in the newly diagnosed patient through the role of hematopoietic stem cell transplantation and maintenance treatment until early and late relapses, including a section on recently approved drugs as well as novel drugs and immunotherapy in advanced stages of research, and that will surely play a relevant role in the treatment of this devastating disease in the coming years.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761116PMC
http://dx.doi.org/10.3390/cancers12123576DOI Listing

Publication Analysis

Top Keywords

multiple myeloma
16
treatment multiple
8
advances treatment
4
treatment patients
4
multiple
4
patients multiple
4
myeloma
4
myeloma years
4
years diseases
4
diseases great
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!